Sign in
Taking people in United StatesPhase 2

Tranexamic acid for joint inflammation and cartilage health after ACL injury

Tests tranexamic acid on joint inflammation in young adults with torn ACL.

Key facts

Who runs it
Stanford University
Where
Stanford, United StatesSee the site
Trial code
Registry title
The Effects of Tranexamic Acid on Joint Inflammation and Cartilage Health in Anterior Cruciate Ligament Injured Patients
Status
Recruiting
Phase
Phase 2
People taking part
50 people, planned
Started
1 Aug 2019
Expected to end
14 Jan 2027
Type of study
Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Tranexamic Acid
  • Placebos
Record updated
27 February 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for young adults who tore the ACL (a main knee ligament) in one knee within the last 4 days and will have ACL repair surgery. It tests whether tranexamic acid lowers joint swelling and protects the cartilage.

Age
18 to 30 years
Sex
All sexes
Disease stage
ACL tear in one knee within 4 days, with fluid or blood in the knee joint. People must be able to have ACL reconstruction surgery within 3 months of the injury.
Earlier treatment
No prior surgery on either knee. No cortisone injection into either knee in the prior 3 months. No long-term use of NSAID pain medicines.

Main reasons for not taking part

  • Inflammatory arthritis, gout or pseudogout, or osteoarthritis seen on X-ray (K-L Grade 2 or higher)
  • Other knee injuries, except a meniscus tear or an MCL tear that does not need surgery
  • Earlier injury to either knee that needed crutches
  • History of blood clots (thromboembolic disease)
  • Current use of combination hormonal birth control

The registry criteria, word for word

Show all 13 criteriaShow less

Who can take part

  • age 18-30 years
  • within 4 days of unilateral ACL injury
  • presence of effusion/hemarthrosis

Who cannot take part

  • concomitant knee injury aside from meniscus tear and MCL tear not requiring surgery
  • prior surgery to either knee
  • prior injury to either knee requiring crutches
  • cortisone injection to either knee within the prior 3 months
  • systemic or acute illness requiring medications
  • history of thromboembolic disease
  • inflammatory arthritis, radiographic osteoarthritis (K-L Grade 2 or higher), gout/ pseudogout
  • current use of combination hormonal contraception
  • chronic NSAID use
  • not indicated for or unable to undergo ACLR within 3 months of injury

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 30 years old?

Where in United States

  • Stanford UniversityStanford, United StatesContact: Christine HoangTaking people

About the trial

What the trial wants to find out

Patients who tear their ACL are at high risk for developing arthritis (post-traumatic osteoarthritis-PTOA) just 10 years later. Joint bleeding and inflammation contribute to deterioration of joint health. This study will determine whether treatment with Tranexamic Acid (TXA), an FDA approved medication that reduces bleeding right after ACL injury and reconstructive surgery reduces inflammation and improves joint health as a new strategy to prevent or delay the onset of PTOA.

The 2 groups in the trial

  • Tranexamic AcidTreatment being tested

    5-day course of standard adult oral tranexamic acid dosage of 1300 mg taken 3 times a day (3900 mg/day) and intravenous tranexamic acid during ACL reconstruction surgery (1 gram of iv TXA just prior to incision and 1 gram of iv TXA just prior to wound closure)

  • PlaceboPlacebo, for comparison

    5-day course of placebo and intravenous saline during ACL reconstruction surgery

    Treatment: Placebos

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Novel Strategies to Combat Post-Traumatic Osteoarthritis (PTOA):The Effects of Tranexamic Acid on Joint Inflammation and Cartilage Health in Anterior Cruciate Ligament Injured Patients
Plain-language title
Tranexamic acid for joint inflammation and cartilage health after ACL injuryGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Fit questions
Built from NCT03552705, who can take part
Record updated
27 February 2026